Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs

Schizophrenia is a chronic psychiatric disorder which substantially impairs patients’ quality of life. Despite the extensive research in this field, the pathophysiology and etiology of schizophrenia remain unknown. Different neurotransmitter systems and functional networks have been found to be affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Muguruza, Carolina, Meana, J. Javier, Callado, Luis F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873505/
https://www.ncbi.nlm.nih.gov/pubmed/27242534
http://dx.doi.org/10.3389/fphar.2016.00130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873505/
https://www.ncbi.nlm.nih.gov/pubmed/27242534
http://dx.doi.org/10.3389/fphar.2016.00130

Ejemplares similares